Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/12/2003WO2001073133A9 Compositions and methods for identifying and targeting cancer cells
06/12/2003US20030110525 Therapy for central nervous system disorders; culture product; transgenic animal
06/12/2003US20030110518 Melanocortin-5 receptor sequences and uses thereof
06/12/2003US20030110169 System and method for providing manageability to security information for secured items
06/12/2003US20030109991 Apparatus and method for detecting twist in articles
06/12/2003US20030109927 Artificial skin and method for evaluating UV screening agent by use of the same
06/12/2003US20030109920 Engineered animal tissue
06/12/2003US20030109806 Reservoir for flood withdrawal
06/12/2003US20030109798 Biosensor apparatus and method with sample type and volume detection
06/12/2003US20030109794 Breath collection apparatus
06/12/2003US20030109691 Variant integrin polypeptides and uses thereof
06/12/2003US20030109689 Using polypeptides; induction immunology response
06/12/2003US20030109686 Methods for evaluating tissue morphogenesis and activity
06/12/2003US20030109683 Hybrid proteins; controlling gene expression in gene therapy; Parkinson's disease
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109672 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030109618 Magnetic, silanised polyvinylalcohol-basedcarrier materials
06/12/2003US20030109536 Treatment of a variety of central nervous system (CNS) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or Alzheimer's dementia,
06/12/2003US20030109483 A purified Parapoxvirus ovis envelope protein termed "B2L" can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response
06/12/2003US20030109464 Galectins -1 and -4 in tumor development
06/12/2003US20030109449 Gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonist of glucogen-like
06/12/2003US20030109444 Bone anti-resorptive compounds
06/12/2003US20030109443 Determining the prognosis for treatment of, and methods for identifying candidate compounds for treating, stabilizing, or preventing cancer, for example, endometrial cancer. These methods utilize the novel tumor suppressor protein, Cables.
06/12/2003US20030109440 Directed to nucleic acids encoding GRB7, which is involved in modulation of T lymphocyte activation and TCR signaling. The invention further relates to methods for identifying and using agents, including small organic molecules, peptides, circular
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109420 Diagnostic markers of acute coronary syndrome and methods of use thereof
06/12/2003US20030109419 Detection and tested for an ability to treat a psychotic disorder in a patient in need of such treatment. The invention provides a method for screening candidate drugs for anti-psychotic drug activity, preferably atypical
06/12/2003US20030109418 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
06/12/2003US20030109067 Homogeneous immunoassays for multiple allergens
06/12/2003US20030109066 Forming drops of mother liquor, crystallization, producing images, computer analyzing; macromolecules of protein; drug screening
06/12/2003US20030109065 High density crystallization experiment device
06/12/2003US20030109064 Automated crystallization experiment setup apparatus
06/12/2003US20030109063 Automated crystallizationexperiment setup apparatus comprising sensor
06/12/2003US20030109062 Immobilization to solid support; screening, detection genes
06/12/2003US20030109057 Apparatus and methods for chemiluminescent assays
06/12/2003US20030109056 Chemical sensors from nanoparticle/dendrimer composite materials
06/12/2003US20030109052 Determination transfer of sample; conductive surface on speciment slide
06/12/2003US20030109051 Spin trap for use in biological systems
06/12/2003US20030109050 Complex of lipoprotein and hemoglobulin; analyzing
06/12/2003US20030109046 Multiwell plate adapted for automated crystallization
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030109039 Enriched central nervous system stem cell and porgenitor cell populations, and methods for identifying, isolating and enriching for such populations
06/12/2003US20030109035 Cell differentiation; tissue engineering; using activin, retinoic acid culture product
06/12/2003US20030109031 System for detecting biological materials in a sample
06/12/2003US20030109023 HIV-producing cell line and uses thereof
06/12/2003US20030109022 Asp2
06/12/2003US20030109018 Novel endometriosis-associated gene
06/12/2003US20030109008 Cell proliferation, cell differentiation; stem cells
06/12/2003US20030109006 Isolation of lymphocytes, binding, forming culture product, cloning
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030109001 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108987 Controlling gene expression; ligand activation; prevent cysts formation in nematodes
06/12/2003US20030108983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030108978 Whole cell assay systems for cell surface proteases
06/12/2003US20030108977 Methods for the identification of inhibitors of pyruvate orthophosphate dikinase expression or activity in plants
06/12/2003US20030108975 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and a SH3 domain comprising peptide
06/12/2003US20030108974 Analyzing antibodies for hepatitis C virus using peptide antigen
06/12/2003US20030108973 Immunoassay and reagents and kits for performing the same
06/12/2003US20030108972 Tethered receptor-ligand reagent and assay
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003US20030108969 Screening bactericides; ppetidoglucan biosynthesis; scintillation
06/12/2003US20030108968 Determination lymphocytes to specific antigen in blood
06/12/2003US20030108967 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108963 Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
06/12/2003US20030108962 Method of cancer estimation by alp isozymes
06/12/2003US20030108961 Methods and compositions for diagnosing breast cancer
06/12/2003US20030108960 Detection antigens to Trypanosoma; antiprotozoa agent; sensitive, accurate analysis
06/12/2003US20030108959 Treating diseases mediated by metalloprotease-shed proteins
06/12/2003US20030108957 Biocidal molecules, macromolecular targets and methods of production and use
06/12/2003US20030108956 Measurement, calibration of potassium channel moderators
06/12/2003US20030108955 Dioxin derivatives and method of measurement therewith
06/12/2003US20030108954 Focusing sound waves
06/12/2003US20030108952 Flow cytometric methods for the concurrent detection of discrete functional conformations of prb in single cells
06/12/2003US20030108951 Screening drugs using antigens; suppress gene expression
06/12/2003US20030108950 Measuring concentration in body fluid of tumor antibodies
06/12/2003US20030108949 Filtration-based microarray chip
06/12/2003US20030108948 Artificial antibody polypeptides
06/12/2003US20030108947 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
06/12/2003US20030108945 Identifying targets of autoreactive T cells in patients with female-prevalent autoimmune diseases and treating these patients
06/12/2003US20030108941 Novel cancer drug screen based on cell cycle uncoupling
06/12/2003US20030108938 Analyzing phenotypes; computer genotype data base
06/12/2003US20030108937 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108930 Method of evaluating drug efficacy and toxicity
06/12/2003US20030108929 Diagnosis of Alzheimer's disease
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108926 Using biochip; determination binding, calibration
06/12/2003US20030108924 Isolated polynucleotide; determination genotype; analyzing
06/12/2003US20030108922 Electrochemical method for detecting water born pathogens
06/12/2003US20030108920 Tumor suppressor-like proteins that bind IGFBP2
06/12/2003US20030108917 Three-dimensional structure; surface sensitivity; analyzing genes
06/12/2003US20030108911 Arrangement and method for multiple-fluorescence measurement
06/12/2003US20030108907 Nucleic acids, proteins, and antibodies
06/12/2003US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering
06/12/2003US20030108901 Serological test for ISAV in fish
06/12/2003US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation
1 ... 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 ... 3937